Home / Inspections / 1204801

FDA Inspection 1204801 — Adare Pharmaceuticals Srl

Adare Pharmaceuticals Srl — FEI 1000573478

The FDA completed an inspection of Adare Pharmaceuticals Srl on October 28, 2022 in Pessano Con Bornago. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 28, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pessano Con Bornago (Italy)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1098299 (VAI Fri Apr 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1006241 (VAI Fri Feb 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 883317 (VAI Fri May 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 793805 (NAI Thu Jul 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 622477 (VAI Fri Oct 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources